Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization

A novel series of 2-styrylquinazolin-4(3H-ones which inhibited tubulin polymerization and the growth of L1210 murine leukemia cells was discovered. Extensive structure-activity relationship studies suggest that the entire quinazolinone structure was required, but activity was further enhanced by hal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1990-06, Vol.33 (6), p.1721-1728
Hauptverfasser: Jiang, Jack B, Hesson, D. P, Dusak, B. A, Dexter, D. L, Kang, G. J, Hamel, E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1728
container_issue 6
container_start_page 1721
container_title Journal of medicinal chemistry
container_volume 33
creator Jiang, Jack B
Hesson, D. P
Dusak, B. A
Dexter, D. L
Kang, G. J
Hamel, E
description A novel series of 2-styrylquinazolin-4(3H-ones which inhibited tubulin polymerization and the growth of L1210 murine leukemia cells was discovered. Extensive structure-activity relationship studies suggest that the entire quinazolinone structure was required, but activity was further enhanced by halide or small hydrophobic substituents at position 6. These analogues did not substantially interfere with the binding of radiolabeled colchicine, vinblastine, or GTP to tubulin and weakly stimulated GTP hydrolysis uncoupled from polymerization. Several analogues have shown in vivo tumor growth inhibitory activity in the L1210 leukemia model, with the lead compound 5o exhibiting good antitumor activity against murine solid tumors as well as human tumor xenografts.
doi_str_mv 10.1021/jm00168a029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79779578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79779578</sourcerecordid><originalsourceid>FETCH-LOGICAL-a475t-eb64ce356229b52ae77fea8614216377a945ccafc53b99e9e3aed80ed238133e3</originalsourceid><addsrcrecordid>eNptkU9v1DAQxSMEKkvhxBnJFwoIAv6TxM4RVUCRVmJRi0BcrIl30vXi2FvboWy_CF-XtLsqHDjNSO-nN6P3iuIxo68Z5ezNeqCUNQoob-8UM1ZzWlaKVneLGaWcl7zh4n7xIKU1pVQwLg6KA06VEhWfFb9Ptz6vMNlEwC9JZ4ML59aAI_gT3AjZBk9CT3iZ8jZu3cVoPVwFZ31ZPRcnL8rgMb0iQDxeEuMgpWsafLaDzSFbc7Mb8AYjgXP0OZHLlTUrYv3KdjaTPHbjZEc2wW0HjPbq5ubD4l4PLuGj_Twsvrx_d3Z8Us4_ffh4_HZeQiXrXGLXVAZF3XDedjUHlLJHUA2rOGuElNBWtTHQm1p0bYstCsClorjkQjEhUBwWRzvfTQwXI6asB5sMOgcew5i0bKVsa6km8OUONDGkFLHXm2gHiFvNqL6uQf9Tw0Q_2duO3YDLW3af-6Q_3euQprD7OAVk01_LVnDFeDNx5Y6zKeOvWx3iD91IIWt9tjjVCzX_vvj2memvE_9sx4NJeh3G6Kfw_vvhH4lSrmU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79779578</pqid></control><display><type>article</type><title>Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization</title><source>ACS Publications</source><source>MEDLINE</source><creator>Jiang, Jack B ; Hesson, D. P ; Dusak, B. A ; Dexter, D. L ; Kang, G. J ; Hamel, E</creator><creatorcontrib>Jiang, Jack B ; Hesson, D. P ; Dusak, B. A ; Dexter, D. L ; Kang, G. J ; Hamel, E</creatorcontrib><description>A novel series of 2-styrylquinazolin-4(3H-ones which inhibited tubulin polymerization and the growth of L1210 murine leukemia cells was discovered. Extensive structure-activity relationship studies suggest that the entire quinazolinone structure was required, but activity was further enhanced by halide or small hydrophobic substituents at position 6. These analogues did not substantially interfere with the binding of radiolabeled colchicine, vinblastine, or GTP to tubulin and weakly stimulated GTP hydrolysis uncoupled from polymerization. Several analogues have shown in vivo tumor growth inhibitory activity in the L1210 leukemia model, with the lead compound 5o exhibiting good antitumor activity against murine solid tumors as well as human tumor xenografts.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00168a029</identifier><identifier>PMID: 2088342</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Chemistry ; Exact sciences and technology ; Heterocyclic compounds ; Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings ; Humans ; Leukemia L1210 - drug therapy ; Mice ; Microtubules - drug effects ; Organic chemistry ; Preparations and properties ; Quinazolines - chemical synthesis ; Quinazolines - pharmacology ; Structure-Activity Relationship ; Styrenes - chemical synthesis ; Styrenes - pharmacology ; Tubulin ; Tumor Cells, Cultured - drug effects</subject><ispartof>Journal of medicinal chemistry, 1990-06, Vol.33 (6), p.1721-1728</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a475t-eb64ce356229b52ae77fea8614216377a945ccafc53b99e9e3aed80ed238133e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00168a029$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00168a029$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19328126$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2088342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Jack B</creatorcontrib><creatorcontrib>Hesson, D. P</creatorcontrib><creatorcontrib>Dusak, B. A</creatorcontrib><creatorcontrib>Dexter, D. L</creatorcontrib><creatorcontrib>Kang, G. J</creatorcontrib><creatorcontrib>Hamel, E</creatorcontrib><title>Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A novel series of 2-styrylquinazolin-4(3H-ones which inhibited tubulin polymerization and the growth of L1210 murine leukemia cells was discovered. Extensive structure-activity relationship studies suggest that the entire quinazolinone structure was required, but activity was further enhanced by halide or small hydrophobic substituents at position 6. These analogues did not substantially interfere with the binding of radiolabeled colchicine, vinblastine, or GTP to tubulin and weakly stimulated GTP hydrolysis uncoupled from polymerization. Several analogues have shown in vivo tumor growth inhibitory activity in the L1210 leukemia model, with the lead compound 5o exhibiting good antitumor activity against murine solid tumors as well as human tumor xenografts.</description><subject>Animals</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Chemistry</subject><subject>Exact sciences and technology</subject><subject>Heterocyclic compounds</subject><subject>Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings</subject><subject>Humans</subject><subject>Leukemia L1210 - drug therapy</subject><subject>Mice</subject><subject>Microtubules - drug effects</subject><subject>Organic chemistry</subject><subject>Preparations and properties</subject><subject>Quinazolines - chemical synthesis</subject><subject>Quinazolines - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Styrenes - chemical synthesis</subject><subject>Styrenes - pharmacology</subject><subject>Tubulin</subject><subject>Tumor Cells, Cultured - drug effects</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU9v1DAQxSMEKkvhxBnJFwoIAv6TxM4RVUCRVmJRi0BcrIl30vXi2FvboWy_CF-XtLsqHDjNSO-nN6P3iuIxo68Z5ezNeqCUNQoob-8UM1ZzWlaKVneLGaWcl7zh4n7xIKU1pVQwLg6KA06VEhWfFb9Ptz6vMNlEwC9JZ4ML59aAI_gT3AjZBk9CT3iZ8jZu3cVoPVwFZ31ZPRcnL8rgMb0iQDxeEuMgpWsafLaDzSFbc7Mb8AYjgXP0OZHLlTUrYv3KdjaTPHbjZEc2wW0HjPbq5ubD4l4PLuGj_Twsvrx_d3Z8Us4_ffh4_HZeQiXrXGLXVAZF3XDedjUHlLJHUA2rOGuElNBWtTHQm1p0bYstCsClorjkQjEhUBwWRzvfTQwXI6asB5sMOgcew5i0bKVsa6km8OUONDGkFLHXm2gHiFvNqL6uQf9Tw0Q_2duO3YDLW3af-6Q_3euQprD7OAVk01_LVnDFeDNx5Y6zKeOvWx3iD91IIWt9tjjVCzX_vvj2memvE_9sx4NJeh3G6Kfw_vvhH4lSrmU</recordid><startdate>19900601</startdate><enddate>19900601</enddate><creator>Jiang, Jack B</creator><creator>Hesson, D. P</creator><creator>Dusak, B. A</creator><creator>Dexter, D. L</creator><creator>Kang, G. J</creator><creator>Hamel, E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900601</creationdate><title>Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization</title><author>Jiang, Jack B ; Hesson, D. P ; Dusak, B. A ; Dexter, D. L ; Kang, G. J ; Hamel, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a475t-eb64ce356229b52ae77fea8614216377a945ccafc53b99e9e3aed80ed238133e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Chemistry</topic><topic>Exact sciences and technology</topic><topic>Heterocyclic compounds</topic><topic>Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings</topic><topic>Humans</topic><topic>Leukemia L1210 - drug therapy</topic><topic>Mice</topic><topic>Microtubules - drug effects</topic><topic>Organic chemistry</topic><topic>Preparations and properties</topic><topic>Quinazolines - chemical synthesis</topic><topic>Quinazolines - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Styrenes - chemical synthesis</topic><topic>Styrenes - pharmacology</topic><topic>Tubulin</topic><topic>Tumor Cells, Cultured - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Jack B</creatorcontrib><creatorcontrib>Hesson, D. P</creatorcontrib><creatorcontrib>Dusak, B. A</creatorcontrib><creatorcontrib>Dexter, D. L</creatorcontrib><creatorcontrib>Kang, G. J</creatorcontrib><creatorcontrib>Hamel, E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Jack B</au><au>Hesson, D. P</au><au>Dusak, B. A</au><au>Dexter, D. L</au><au>Kang, G. J</au><au>Hamel, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1990-06-01</date><risdate>1990</risdate><volume>33</volume><issue>6</issue><spage>1721</spage><epage>1728</epage><pages>1721-1728</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A novel series of 2-styrylquinazolin-4(3H-ones which inhibited tubulin polymerization and the growth of L1210 murine leukemia cells was discovered. Extensive structure-activity relationship studies suggest that the entire quinazolinone structure was required, but activity was further enhanced by halide or small hydrophobic substituents at position 6. These analogues did not substantially interfere with the binding of radiolabeled colchicine, vinblastine, or GTP to tubulin and weakly stimulated GTP hydrolysis uncoupled from polymerization. Several analogues have shown in vivo tumor growth inhibitory activity in the L1210 leukemia model, with the lead compound 5o exhibiting good antitumor activity against murine solid tumors as well as human tumor xenografts.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>2088342</pmid><doi>10.1021/jm00168a029</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1990-06, Vol.33 (6), p.1721-1728
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_79779578
source ACS Publications; MEDLINE
subjects Animals
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - pharmacology
Chemistry
Exact sciences and technology
Heterocyclic compounds
Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings
Humans
Leukemia L1210 - drug therapy
Mice
Microtubules - drug effects
Organic chemistry
Preparations and properties
Quinazolines - chemical synthesis
Quinazolines - pharmacology
Structure-Activity Relationship
Styrenes - chemical synthesis
Styrenes - pharmacology
Tubulin
Tumor Cells, Cultured - drug effects
title Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T20%3A39%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20biological%20evaluation%20of%202-styrylquinazolin-4(3H)-ones,%20a%20new%20class%20of%20antimitotic%20anticancer%20agents%20which%20inhibit%20tubulin%20polymerization&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jiang,%20Jack%20B&rft.date=1990-06-01&rft.volume=33&rft.issue=6&rft.spage=1721&rft.epage=1728&rft.pages=1721-1728&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00168a029&rft_dat=%3Cproquest_cross%3E79779578%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79779578&rft_id=info:pmid/2088342&rfr_iscdi=true